2025-05-02 09:12:12
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Alembic Pharmaceuticals Ltd Q4FY21 consolidated net profit drops QoQ to Rs. 237.41 crores
Posted On : 2021-05-04 14:52:26( TIMEZONE : IST )
ALEMBIC PHARMACEUTICALS LTD. has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.1284.34 crores during the period ended March 31, 2021 as compared to Rs.1316.86 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.237.41 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.259.21 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.12.75 for the period ended March 31, 2021 as compared to Rs.14.88 for the period ended December 31, 2020.
| Financials | Q4 FY20-21 | Q3 FY20-21 | % Change |
| Total Income | ₹ 1284.34 crs | ₹ 1316.86 crs |  -2.47% |
| Net Profit | ₹ 237.41 crs | ₹ 259.21 crs | -8.41% |
| EPS | ₹ 12.75 | ₹ 14.88 | -14.31% |
Financial Results (Q4 FY20-21) - YoY Comparison
The company has reported total income of Rs.1284.34 crores during the period ended March 31, 2021 as compared to Rs.1207.72 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.237.41 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.203.52 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.12.75 for the period ended March 31, 2021 as compared to Rs.11.92 for the period ended March 31, 2020.
| Financials | Q4 FY20-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 1284.34 crs | ₹ 1207.72 crs |  6.34% |
| Net Profit | ₹ 237.41 crs | ₹ 203.52 crs | 16.65% |
| EPS | ₹ 12.75 | ₹ 11.92 | 6.96% |
Financial Results (Year ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.5403.14 crores during the 12 months period ended March 31, 2021 as compared to Rs.4610.69 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.1114.76 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.800.64 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.60.81 for the 12 months period ended March 31, 2021 as compared to Rs.43.97 for the 12 months period ended March 31, 2020.
| Financials | Year Ended FY20-21 | Year Ended FY19-20 | % Change |
| Total Income | ₹ 5403.14 crs | ₹ 4610.69 crs | 17.19% |
| Net Profit | ₹ 1114.76 crs | ₹ 800.64 crs | 39.23% |
| EPS | ₹ 60.81 | ₹43.97 | 38.3% |
Mr. Pranav Amin, Managing Director, Alembic Pharmaceuticals Limited said, "It was an outstanding year with the company recording its highest sales and profit ever. This was led by strong growth in the API and International Business. The operating teams worked tirelessly through the pandemic to ensure critical supplies were uninterrupted."
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.983 as compared to the previous close of Rs. 985.45. The total number of shares traded during the day was 26650 in over 621 trades.
The stock hit an intraday high of Rs. 999.4 and intraday low of 976.2. The net turnover during the day was Rs. 26202260.
